The price of this share is at 172,36$, Reata Pharmaceuticals Inc is a company created in United States dedicated to Biotechnology: Pharmaceutical Preparations with its highest number of sales in North America. Its Executives are Colin J. Meyer (Chief Research & Development Officer, Executive VP), Edmund Doherty (Vice President-Medical Affairs), J. Warren Huff (Chairman, President & Chief Executive Officer), Manmeet Singh Soni (Executive VP, Chief Operating & Financial Officer), Samina Khan (Chief Medical Officer & Senior Vice President), W. Christian Wigley (Chief Scientific Officer, SVP & Founding Scientist) and its address is 5320 LEGACY DRIVE, PLANO, Texas, 75024, United States.

The closing price of the stock yesterday was desconocido$.

The current range on the same day is from 172,32$ - 172,46$, with a percentage difference of 172,39$ quite wide that helps to be able to do day trading.

The company has an annual revenue of desconocido.

The opening price that appears as last recorded is desconocido.

To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.

EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].